We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00210366
Recruitment Status : Terminated (due to slow accrual)
First Posted : September 21, 2005
Last Update Posted : July 30, 2010
Information provided by:
International Extranodal Lymphoma Study Group (IELSG)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2010
  Study Completion Date : No date given